Literature DB >> 1125586

Comparison of debrisoquine and guanethidine in treatment of hypertension.

F C Adi, C J Eze, A Anwunah.   

Abstract

A cross-over trail of debrisoquine and guanethidine in 32 patients showed that both drugs were equally effective in lowering both systolic and diastolic blood pressure. The degree to which they were tolerated by the patients, however, differed greatly. After three months on each drug 18 patients preferred debrisoquine, nine preferred guanethidine, and five showed no particular preference. At current prices the cost of daily treatment to the patient was cheaper with debrisoquine than with guanethidine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125586      PMCID: PMC1672541          DOI: 10.1136/bmj.1.5956.482

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Clinical observations on the use of debrisoquine sulphate (Declinas) in the treatment of hypertension.

Authors:  A G Heffernan; A T Carty
Journal:  Ir J Med Sci       Date:  1970-01       Impact factor: 1.568

2.  A within-patient comparison of debrisoquine and methyldopa in hypertension.

Authors:  A Heffernan; A Carty; K O'Malley; J Bugler
Journal:  Br Med J       Date:  1971-01-09
  2 in total
  2 in total

1.  Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.

Authors:  S Talbot; B C O'Malley; R H Bing
Journal:  Br Med J       Date:  1975-05-03

2.  Comparative studies of guanfacine and methyldopa.

Authors:  A Roeckel; A Heidland
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.